Rakuten Medical Japan Announces Marketing Approval of Akalux(R) IV Infusion 250mg and BioBlade(R) Laser System from the Ministry of Labour, Health and Welfare in Japan for Locoregional Cancer Treatment

SAN MATEO, Calif., Sept. 25, 2020 -- (Healthcare Sales & Marketing Network) -- Rakuten Medical Inc. is proud to announce that its wholly owned subsidiary Rakuten Medical Japan K.K. has received marketing approval in Japan from the Ministry of Health, Labo... Biopharmaceuticals, Oncology, Regulatory Rakuten Medical, Akalux, cetuximab saratolacan, BioBlade Laser, Illuminox
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news